Filing Details
- Accession Number:
- 0001140361-18-035892
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-07 18:01:55
- Reporting Period:
- 2018-08-03
- Accepted Time:
- 2018-08-07 18:01:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1442078 | V. Sophie Vandebroek | One Idexx Drive Wesbrook ME 04092 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-08-03 | 2,952 | $46.91 | 9,127 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-08-03 | 1,515 | $240.64 | 7,612 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-08-03 | 2,986 | $64.69 | 10,598 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-08-03 | 1,750 | $240.64 | 8,848 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right-to-buy) | Disposition | 2018-08-03 | 2,952 | $0.00 | 2,952 | $46.91 |
| Common Stock | Non-Qualified Stock Option (right-to-buy) | Disposition | 2018-08-03 | 2,986 | $0.00 | 2,986 | $64.69 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2023-08-31 | No | 4 | M | Direct | |
| 2,988 | 2024-05-06 | No | 4 | M | Direct |
Footnotes
- Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 3,476 shares on May 7, 2014, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
- Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 2,987 shares on May 7, 2015, without giving effect to the Stock Split. The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
- Not applicable.
Billionaire Hedge Funds
